[Skip to Navigation]
Sign In
Correction
December 17, 2020

Misspelled Author Name and Funding Source

JAMA Oncol. 2021;7(2):312. doi:10.1001/jamaoncol.2020.7373

In the original investigation titled “Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome,”1 published online October 30, 2020, an author’s name was misspelled: “Keith A. Stewart” has now been changed to “A. Keith Stewart.” Also, the name of a funding source was misspelled: “Mayo Transform the Practice Grant” has been changed to “Mayo Practice Transformation Grant.” This article has been corrected online.

References
1.
Samadder  NJ, Riegert-Johnson  D, Boardman  L,  et al.  Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome.   JAMA Oncol. Published online October 30, 2020. doi:10.1001/jamaoncol.2020.6252Google Scholar
×